Around 5,530 employees will be cut from the Research and Development area and in the US, big losses in Connecticut. Lipitor is due to come off patent near the end of this year so sales will be impacted there. Lipitor has not been without issues either this last year as many bottles stunk...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Feb 2 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, Heart Disease, Pediatrics, Diabetes, Budgets, Pfizer, Research and Development, Lipitor, Job cuts, children, cholesterol, chewable
The Governor speaks in a humorous but nice way on all the donations Eli and Edythe Broad have made and how he’s following them around as they have made big donations up north and at UCLA. There has been 3 billion dollars set aside for research and 1 billion in grants have been given and so much...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Oct 29 2010
Filed under:
Filed under: Medically Related, Technology, Clincal Trials, Diabetes, California, Politics, Research and Development, Stem Cells, Schwarzenegger, Regenerative Medicine, eyesight, macular degeneration, therapies, Eli and Edythe Broad Center
This is something we all worry about when taking drugs as the liver is the organ that usually stands the chance of being damaged and it is the most common cause of liver failure in the US, so yes we want to know what drugs are potentially toxic, whether in dose or over extended use. If you call...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, May 27 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Diabetes, Nutrition, Research and Development, Liver, Urology, kidneys, NIH Foundation, side effects AstraZeneca, NIDDK
This is the big question on the minds of the FDA, Congress and others. Are you getting treatment for one ailment and creating another one? Who has the best drug with the least amount of side effects and what’s in it for profit? It is somewhat amazing with transparency the questions...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Feb 22 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, FDA, Diabetes, Safety, Side Effects, Research and Development, Transparency, heart attacks, Glaxo Smith Kline, Avandia
Once again we return to the software issues, the algorithms, and who thinks these don’t shape the world today. Good choice with Johnson and Johnson to develop and work on the project. The device would have 2 working parts, but the tricky part is the human side, in other words to have the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Jan 13 2010
Filed under:
Filed under: Medically Related, Technology, Medical Devices, Diabetes, Heatlhcare, Johnson and Johnson, Research and Development, wireless, blue tooth, e-Zassi, Artificial Pancreas, Diabetes pump
Metformin is one of the most commonly prescribed drugs for diabetes. The article states that being this is a well known and documented drug that trials would not be an issue as many are already taking the medication. It is also the only anti-diabetic drug know to protect against the...